What an Immune Study May Mean for Blood Pressure in MS
By MS Buddy ·
Summarized from Cardiovascular research, Oct 2026 · PubMed. AI-generated summary. Not medical advice.
Research by Masudur Rahman, Johannes Stegbauer and 16 colleagues at Heinrich-Heine-University, University Hospital Würzburg and 2 other institutions in Germany and China.
Key Takeaway
Immune cells from people with hard-to-control high blood pressure made blood pressure rise more in mice, but the study did not test people with MS.
What They Found
Researchers put blood cells from people with hard-to-control high blood pressure into mice with weak immune systems. They gave the mice a substance that raises blood pressure. Blood pressure rose more in mice given cells from people with high blood pressure than in mice given cells from healthy people. The first group also had more trouble with blood vessels relaxing, which helps blood flow. A signal called TNF, made by certain immune cells, appeared to play a part: blocking it reduced the blood pressure rise in these mice.
Who Should Care and Why
People with MS and their caregivers may find this study useful because it shows one way immune cells might affect blood pressure. It does not show that MS causes high blood pressure or that the same process happens in people with MS. If you track your blood pressure, keep sharing the readings with your care team, especially if they stay high despite treatment. Think of this study as a clue for researchers, not a new step to add to your daily care. Do not change an MS or blood pressure treatment because of these results; ask your clinician about any concerns.
Important Considerations
The main tests were done in mice, so the results may not apply to people. The donated cells came from people with hard-to-control high blood pressure, not from people selected for having MS. Blocking TNF helped the mice, but this study did not show that a TNF-blocking treatment is safe or helpful for people with MS.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Cardiovascular research by et al.. Reproduced from the PubMed record.
Preclinical studies suggest a pivotal role of adaptive immunity, particularly T cells, in hypertension. However, due to the multifactorial pathogenesis, there is still no definitive evidence for a causal role of T cells in the development of hypertension in humans. We sought to determine whether T cells from patients with treatment-resistant hypertension (TRH) directly modulate blood pressure and vascular function in vivo. Peripheral blood mononuclear cells (PBMCs) from TRH patients and healthy controls (HC) were adoptively transferred into immunodeficient NSG-(KbDb)^null mice. Hypertension was induced by angiotensin II infusion for 14 days and monitored continuously by radiotelemetry. Following T cell engraftment, blood pressure was assessed at baseline and during AngII infusion in both groups of recipient mice. At baseline, systolic blood pressure did not differ between both groups. However, mice receiving TRH-PBMCs developed a significantly higher systolic blood pressure following AngII compared with HC-PBMC recipients. Endothelial dysfunction in isolated perfused kidneys was more pronounced in AngII-challenged TRH-PBMC recipients compared to HC-PBMC recipients. TRH-PBMC recipients displayed elevated effector memory CD4+ T cells and Th17 frequencies in spleen and kidney, along with markedly increased renal expression of human T cell-derived TNF. Overnight incubation of mouse aortic rings with human TNF induced endothelial dysfunction, indicating a causal role of T cell-derived TNF. As a proof of concept, TNF inhibition attenuated AngII-induced hypertension in TRH-PBMC-engrafted mice. T cells from patients with treatment-resistant hypertension promote an exaggerated hypertensive response and endothelial dysfunction in PBMC-engrafted humanized mice, promoted by TNF-mediated mechanisms. These findings provide evidence that T cell-derived TNF may contribute to the pathogenesis of human hypertension.
Explore more research
Related MS research
11/8/2026
A study finds a short survey may help spot worry about the unknown in people with MS. Learn what it
Read More11/9/2026
A U.S. study found anxiety, depression, and pain more often in MS hospital stays. Learn why asking f
Read More11/7/2026
A study of 360 people with MS links past suicide attempts with depression, smoking, and childhood ha
Read More11/4/2026
Could a short voice recording help track MS changes? Learn why speech-checking tools show promise fo
Read More11/4/2026
A four-year MS study links the condition of nerve coating in brain lesions with later thinking speed
Read More11/3/2026
A study of two MS medicines found MRI scans may help confirm relapses and clarify treatment differen
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
